The Role of Gut Microbiota in Immunomodulation and Autoimmune Diseases: A Comprehensive Review

Olaa  Moyad Ali

doi:10.55640/ijmsdh-09-12-09

Open Access

The Role of Gut Microbiota in Immunomodulation and Autoimmune Diseases: A Comprehensive Review

Vol. 9 No. 12 (2023): Volume 09 Issue 12 | Pages: 47-61 | https://doi.org/10.55640/ijmsdh-09-12-09

Authors

Olaa Moyad Ali
University of Diyala, College of Education for Pure Sciences
https://orcid.org/0009-0006-2924-1918

Views: 56 Downloads: 91
Google Scholar

Published Date: 2023-12-24
Download PDF: PDF

Copyright License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the rights to their work published in the International Journal of Medical Science and Dental Health and may republish or reproduce their own work, provided proper citation to the original publication in IJMSDH is included.

How to Cite

The Role of Gut Microbiota in Immunomodulation and Autoimmune Diseases: A Comprehensive Review. (2023). International Journal of Medical Science and Dental Health, 9(12), 47-61. https://doi.org/10.55640/ijmsdh-09-12-09

More Citation Formats

Download Citation

Downloads

Download data is not yet available.

Abstract

The investigation into autoimmune conditions, particularly the intricate interplay between the gut microbiome and the immune response, has emerged as a critical domain of scholarly scrutiny. This review article provides a comprehensive analysis of prevailing views on the role of the gut microbiota in immune regulation and the development of autoimmune diseases. We begin this study by explaining the basic interactions of gut microorganisms and their relationship with the immune system. We then discuss dysbacteriosis and its implications for immune dysfunction, thus understanding the initiation of autoimmune reactions.

Next, we delve into a section examining and reviewing clinical research findings identifying associations between differences in gut microbial compositions and various autoimmune diseases such as inflammatory bowel disease, rheumatoid arthritis, type 1 diabetes.

In conclusion, this review addresses the methodological challenges that currently impede progress in this field and suggests approaches and plans for future research that may advance our understanding of the critical role played by the gut microbiota in the prevention, diagnosis, and treatment of autoimmune diseases. The article emphasizes the need to combine strategies to improve patient prognosis in cases of autoimmune diseases.

References

Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474(11):1823-36.

Takiishi T, Fenero CIM, Câmara NOS. Intestinal barrier and gut microbiota: Shaping our immune responses throughout life. Tissue Barriers. 2017;5(4):e1373208.

Bull MJ, Plummer NT. Part 1: The Human Gut Microbiome in Health and Disease. Integr Med (Encinitas). 2014;13(6):17-22.

Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota. World J Gastroenterol. 2015;21(29):8787-803.

Fakharian F, Thirugnanam S, Welsh DA, Kim W-K, Rappaport J, Bittinger K, et al. The Role of Gut Dysbiosis in the Loss of Intestinal Immune Cell Functions and Viral Pathogenesis. Microorganisms. 2023;11(7):1849.

Wiertsema SP, van Bergenhenegouwen J, Garssen J, Knippels LMJ. The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies. Nutrients. 2021;13(3).

Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30(6):492-506.

Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121-41.

Chu H, Mazmanian SK. Innate immune recognition of the microbiota promotes host-microbial symbiosis. Nat Immunol. 2013;14(7):668-75.

Wu HJ, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes. 2012;3(1):4-14.

Belkaid Y, Naik S. Compartmentalized and systemic control of tissue immunity by commensals. Nat Immunol. 2013;14(7):646-53.

Portincasa P, Bonfrate L, Vacca M, De Angelis M, Farella I, Lanza E, et al. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis. Int J Mol Sci. 2022;23(3).

Lin L, Zhang J. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunology. 2017;18(1):2.

Mohammed ZJ, Sharba MM, Mohammed AA. THE EFFECT OF CIGARETTE SMOKING ON HAEMATOLOGICAL PARAMETERS IN HEALTHY COLLEGE STUDENTS IN THE CAPITAL, BAGHDAD. European Journal of Molecular & Clinical Medicine

Hold GL, Smith M, Grange C, Watt ER, El-Omar EM, Mukhopadhya I. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World J Gastroenterol. 2014;20(5):1192-210.

Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T, et al. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Pathogens. 2019;8(3).

Chen Y, Cui W, Li X, Yang H. Interaction Between Commensal Bacteria, Immune Response and the Intestinal Barrier in Inflammatory Bowel Disease. Front Immunol. 2021;12:761981.

Saez A, Herrero-Fernandez B, Gomez-Bris R, Sánchez-Martinez H, Gonzalez-Granado JM. Pathophysiology of Inflammatory Bowel Disease: Innate Immune System. International Journal of Molecular Sciences. 2023;24(2):1526.

Escribano-Vazquez U, Verstraeten S, Martin R, Chain F, Langella P, Thomas M, et al. The commensal Escherichia coli CEC15 reinforces intestinal defences in gnotobiotic mice and is protective in a chronic colitis mouse model. Sci Rep. 2019;9(1):11431.

Ju T, Bourrie BCT, Forgie AJ, Pepin DM, Tollenaar S, Sergi CM, et al. The Gut Commensal Escherichia coli Aggravates High-Fat-Diet-Induced Obesity and Insulin Resistance in Mice. Appl Environ Microbiol. 2023;89(3):e0162822.

Abt M, Lewis B, Caballero S, Xiong H, Carter R, Sušac B, et al. Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection. Cell host & microbe. 2015;18:27-37.

Al-Karawi AS, Rasool KH, Atoom AM, Kadhim AS. Correlation between H. pylori infection and serum levels of inflammatory markers: A retrospective study. Al-Salam Journal for Medical Science. 2023;2(2):20-4.

Kadhim AS, Al-Karawi AS. Insights into the Pathogenesis, Virulence Factors, and Diagnosis of Helicobacter pylori: A Comprehensive Review. American Journal of Bioscience and Bioinformatics. 2023;2(1):31-7.

Ahmed N. 23 years of the discovery of Helicobacter pylori: is the debate over? Ann Clin Microbiol Antimicrob. 2005;4:17.

Sheh A, Fox JG. The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes. 2013;4(6):505-31.

Tawfik SA, Azab M, Ramadan M, Shabayek S, Abdellah A, Al Thagfan SS, et al. The Eradication of Helicobacter pylori Was Significantly Associated with Compositional Patterns of Orointestinal Axis Microbiota. Pathogens. 2023;12(6):832.

Lo CH, Wu DC, Jao SW, Wu CC, Lin CY, Chuang CH, et al. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas. J Biomed Sci. 2022;29(1):88.

Huh JW, Kim MJ, Kim J, Lee HG, Ryoo SB, Ku JL, et al. Enterotypical Prevotella and three novel bacterial biomarkers in preoperative stool predict the clinical outcome of colorectal cancer. Microbiome. 2022;10(1):203.

Zhuang Y-P, Zhou H-L, Chen H-B, Zheng M-Y, Liang Y-W, Gu Y-T, et al. Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application. Biomedicine & Pharmacotherapy. 2023;165:115040.

Xu H, Liu M, Cao J, Li X, Fan D, Xia Y, et al. The Dynamic Interplay between the Gut Microbiota and Autoimmune Diseases. J Immunol Res. 2019;2019:7546047.

Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002;15(1):79-94.

Ramos GP, Papadakis KA. Mechanisms of Disease: Inflammatory Bowel Diseases. Mayo Clin Proc. 2019;94(1):155-65.

Al-Karawi AS, Alawssi YF, Khadhum MK. Immunological Insights into Rheumatoid Arthritis: A Comprehensive Review of Diagnosis and Assessment Approaches. African Journal of Advanced Pure and Applied Sciences (AJAPAS). 2023:151-9.

Conforti A, Di Cola I, Pavlych V, Ruscitti P, Berardicurti O, Ursini F, et al. Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmunity reviews. 2021;20(2):102735.

Okada Y, Eyre S, Suzuki A, Kochi Y, Yamamoto K. Genetics of rheumatoid arthritis: 2018 status. Annals of the rheumatic diseases. 2019;78(4):446-53.

Gulati M, Farah Z, Mouyis M. Clinical features of rheumatoid arthritis. Medicine. 2018;46(4):211-5.

Bullock J, Rizvi SAA, Saleh AM, Ahmed SS, Do DP, Ansari RA, et al. Rheumatoid Arthritis: A Brief Overview of the Treatment. Med Princ Pract. 2018;27(6):501-7.

McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. New England Journal of Medicine. 2011;365(23):2205-19.

Roep BO, Thomaidou S, van Tienhoven R, Zaldumbide A. Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?). Nat Rev Endocrinol. 2021;17(3):150-61.

Houeiss P, Luce S, Boitard C. Environmental Triggering of Type 1 Diabetes Autoimmunity. Front Endocrinol (Lausanne). 2022;13:933965.

Constantinescu CS, Farooqi N, O'Brien K, Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol. 2011;164(4):1079-106.

Robinson AP, Harp CT, Noronha A, Miller SD. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol. 2014;122:173-89.

Schmidt CW. Questions persist: environmental factors in autoimmune disease. Environ Health Perspect. 2011;119(6):A249-53.

Jörg S, Grohme DA, Erzler M, Binsfeld M, Haghikia A, Müller DN, et al. Environmental factors in autoimmune diseases and their role in multiple sclerosis. Cell Mol Life Sci. 2016;73(24):4611-22.